Company: LGN
Filing Date: 2025-11-03
Form Type: DRS
Source: 0001193125-25-262782
Chunk: 338

Company: Legence Corp.
Filing Date: 2025-11-03
Form: DRS
Chunk 338
---
8-K filed on September 15, 2025).                                                                                                                         |
| 21.1    |     | List of subsidiaries of Legence Corp. (incorporated by reference to Exhibit 21.1 to the Company’s Registration Statement on Form S-1 (File                                                                                                                           
 No. 333-289629) filed on August 15, 2025).                                                                                                                                                                                                                           |
| 23.1*   |     | Consent of Kirkland & Ellis LLP (included as part of Exhibit 5.1 hereto).                                                                                                                                                                                            |
| 23.2*   |     | Consent of Deloitte & Touche LLP, as to Legence Corp.                                                                                                                                                                                                                |
| 23.3*   |     | Consent of Deloitte & Touche LLP, as to Legence Holdings LLC.                                                                                                                                                                                                        |
| 24.1*   |     | Power of Attorney (included on the signature page of this registration statement).                                                                                                                                                                                   |
| 107*    |     | Filing Fee Table.                                                                                                                                                                                                                                                    |

| * | To be filed by amendment. |

II-4

Confidential Treatment Requested by Legence Corp. Pursuant to 17 C.F.R. Section 200.83

| † | Certain of the schedules and exhibits to the agreement have been omitted pursuant to Item 601(a)(5) of                                   
 Regulation S-K. A copy of any omitted schedule or exhibit will be furnished to the U.S. Securities and Exchange Commission upon request. |

| + | Indicates management contract or compensatory plan. |

Item 17. Undertakings.

| (a) | Insofar as indemnification for liabilities arising under the Securities Act of 1933 may be permitted to                                                                                                                                                
 directors, officers and controlling persons of the registrant pursuant to the foregoing provisions, or otherwise, the registrant has been advised that in the opinion of the Securities and Exchange Commission such indemnification is against public 
 policy as expressed in the Securities Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the registrant of expenses incurred or paid by a director, officer or    
 controlling person of the registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the registrant will, unless in the   
 opinion of its counsel the matter has been settled by controlling precedent, submit to